{
    "SPADE_UN_24001": {
        "Sequence Information": {
            "Peptide Name": "G-LL-37 (15-32)/GF-17 [F17,27BIP; I20,24l; L28l]",
            "Sequence": "GXKRLVQRLKDXLRKLV",
            "Sequence Length": 17,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P49913",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P49913",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model.",
                    "Pubmed ID": "31319057",
                    "Reference": "Biochim Biophys Acta. 2019;1861:1592-1602",
                    "Author": "Narayana JL, Mishra B, Lushnikova T, Golla RM, Wang G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31319057"
                }
            ],
            "SPADE ID": "SPADE_UN_24001",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00227",
                    "Similarity": 1.0,
                    "Sequence": "QGIGVGDNDGKRGKR"
                },
                {
                    "SPADE_ID": "SPADE_UN_23953",
                    "Similarity": 1.0,
                    "Sequence": "GKRLVQRLKDWLRKLV"
                },
                {
                    "SPADE_ID": "SPADE_UN_23954",
                    "Similarity": 1.0,
                    "Sequence": "GKRLVQRLKDWLRKLV"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:61.5% Hemolysis=220 µM,Human erythrocytes:50% Hemolysis=180 µM,Human embryonic kidney HEK293 cells:50% Cytotoxicity=>25 µM,Human keratinocytes HaCat:50% Cytotoxicity=>25 µM",
            "Target Organism": "Enterococcus faecium ATCC 51559(MIC=3.1µM),Staphylococcus aureus USA 300(MIC=3.1µM),Klebsiella pneumoniae ATCC 13883(MIC=3.1µM),Acinetobacter baumannii B28-16(MIC=3.1µM),Pseudomonas aeruginosa PAO1(MIC=6.25µM),Enterobacter cloacae B2366-12(MIC=6.25µM),Staphylococcus aureus Newman(MIC=3.1µM),Staphylococcus aureus MU50(MIC=3.1-6.25µM),Staphylococcus aureus SA546(MIC=3.1µM),Staphylococcus aureus UAMS-1(MIC=3.1µM),Human acute monocytic leukemia THP-1(50-60% Cytotoxicity=>12.5µM)"
        }
    }
}